chr5-75351155-G-C
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 1P and 2B. PP2BP4_Moderate
The NM_000859.3(HMGCR):āc.1029G>Cā(p.Glu343Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000893 in 1,612,912 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_000859.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HMGCR | NM_000859.3 | c.1029G>C | p.Glu343Asp | missense_variant | 10/20 | ENST00000287936.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HMGCR | ENST00000287936.9 | c.1029G>C | p.Glu343Asp | missense_variant | 10/20 | 1 | NM_000859.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000462 AC: 7AN: 151422Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250830Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135620
GnomAD4 exome AF: 0.0000937 AC: 137AN: 1461490Hom.: 0 Cov.: 31 AF XY: 0.0000990 AC XY: 72AN XY: 727074
GnomAD4 genome AF: 0.0000462 AC: 7AN: 151422Hom.: 0 Cov.: 32 AF XY: 0.0000406 AC XY: 3AN XY: 73966
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 20, 2023 | The c.1029G>C (p.E343D) alteration is located in exon 10 (coding exon 9) of the HMGCR gene. This alteration results from a G to C substitution at nucleotide position 1029, causing the glutamic acid (E) at amino acid position 343 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at